Ke-Shu Zhou, Shuling Hou, Yan Zhang, Fei Li, Wei Yang, Tienan Yi, Ningjing Lin, Wei Meng, Xingchen Liu, Ying Chen, Qiying Lu, Wenzhi Tian, Yuqin Song. "Updated efficacy and safety results from the phase 2 study of timdarpacept in combination with tislelizumab in patients with classical Hodgkin lymphoma for whom prior anti–PD-1 therapy failed.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7041